Vaidya Sane Ayurved Laboratories LimitedMADHAVBAUGCorporate

Healthcare Latest results: Mar 2026 10 quarters of data

₹167.95

MCap ₹177 Cr · P/E 21.7

Vaidya Sane Ayurved Laboratories Limited — Stock analysis & AI research Vaidya Sane Ayurved Laboratories Limited — Seasonality — best & worst months Vaidya Sane Ayurved Laboratories Limited — Live exchange announcements

🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹100 Cr

Sales · Mar 2026

+116.1% YoY

₹10 Cr

Operating Profit · Mar 2026

+57.3% YoY

10.4%

OPM % · Mar 2026

-26.8% YoY

₹5 Cr

Net Profit · Mar 2026

+94.3% YoY

₹4.69

EPS · Mar 2026

+93.8% YoY

📝 Vaidya Sane Ayurved Laboratories Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Vaidya Sane Ayurved Laboratories Limited reported revenue of ₹100 crore for the quarter ended March 2026 (Q4 FY26), up 116.1% from ₹46 crore in the same quarter last year.

Net profit rose 94.3% year-on-year to ₹5 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹4.69.

Operating profit stood at ₹10 crore — an operating margin (OPM) of 10.4%, compared with 14.2% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹147 crore with a net profit of ₹8 crore.

Valuation snapshot

At the current price of ₹167.95, MADHAVBAUG has a market capitalisation of ₹177 crore and a trailing P/E of about 21.7.

Within the Healthcare industry, it is the 17th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 66.34%, domestic institutional investors (DIIs) 0.00%, public shareholders 33.66% of Vaidya Sane Ayurved Laboratories Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹177 Cr

Current Price ?

₹167.9

P/E ?

21.65below ind

Industry P/E ?

34.70

P/B ?

2.20

P/S ?

1.20

P/FCF ?

-53.51

Enterprise Value ?

₹179 Cr

EV/EBITDA ?

10.71

PEG ?

N/A

Earnings Yield ?

4.7%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹147 Cr

OPM ?

11.4%

Profit after tax (TTM) ?

₹8 Cr

EPS (TTM) ?

₹7.76

ROCE ?

9.6%

ROE ?

10.1%

ROA ?

8.4%

Growth

Sales — latest qtr ?

₹100 Cr

PAT — latest qtr ?

₹5 Cr

YoY qtr sales growth ?

116.1%

YoY qtr profit growth ?

94.3%

Sales growth (3y) ?

Sales growth (5y) ?

14%

Profit growth (3y) ?

-2%

Profit growth (5y) ?

40%

Financial Health

Debt ?

₹3 Cr

Debt to Equity ?

0.03

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

66.34%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-18.0%

Return 6 months ?

-9.8%

🗓️ Quarterly results (10 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026	YoY %	QoQ %
Sales	31	43	46	54	50	47	41	46	47	100	+116.1%	—
Operating Profit	3	4	4	4	2	1	4	7	6	10	+57.3%	—
Other Income	0	0	1	1	0	1	1	-0	1	2	+881.1%	—
Interest	0	0	0	0	0	0	0	1	0	1	+3.4%	—
Depreciation	1	1	1	1	2	1	2	2	3	6	+186.4%	—
Profit Before Tax	1	3	4	3	1	1	3	4	4	6	+72.0%	—
Net Profit	1	2	3	2	0	1	2	3	3	5	+94.3%	—
EPS	1.94	2.01	2.86	2.07	0.40	0.60	2.25	2.42	3.06	4.69	+93.8%	—
OPM %	8.3%	9.9%	9.8%	7.3%	3.6%	2.9%	10.6%	14.2%	13.6%	10.4%	-26.8%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	10.51	10.51	10.51	10.51	+0.0%
Reserves	30.30	44.51	49.19	69.88	+42.1%
Borrowings	0.13	1.68	1.46	2.59	+77.4%
Other Liabilities	14.34	14.03	12.67	14.02	+10.7%
Total Liabilities	55.28	70.73	73.83	97.00	+31.4%
Fixed Assets	20.95	22.08	26.97	28.69	+6.4%
CWIP	1.67	2.60	1.26	1.40	+11.1%
Investments	14.85	24.88	26.38	43.21	+63.8%
Other Assets	17.81	21.17	19.22	23.70	+23.3%
Total Assets	55.28	70.73	73.83	97.00	+31.4%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	-0.43	3.39	7.58	4.17	-45.0%
Cash from Investing Activity	1.00	-17.42	-6.91	-22.08	-219.5%
Cash from Financing Activity	-1.38	14.46	-0.54	16.73	+3198.1%
Net Cash Flow	-0.81	0.43	0.14	-1.17	-935.7%
Free Cash Flow	-7.41	-1.70	0.31	-3.30	-1164.5%
CFO/OP	24%	129%	85%	61%	-28.2%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	23.81	21.90	29.46	34.88	+18.4%
Inventory Days	—	39.92	31.08	19.42	-37.5%
Days Payable	—	113.10	111.56	96.97	-13.1%
Cash Conversion Cycle	23.81	-51.28	-51.02	-42.67	+16.4%
Working Capital Days	1.51	-5.25	-3.52	89.14	+2632.4%
ROCE %	19.93%	3.07%	13.86%	9.57%	-31.0%

👥 Shareholding (latest 4 periods)

Metric	Mar 2025	Sep 2025	Dec 2025	Mar 2026	% Chg
Promoters	66.34%	66.34%	66.34%	66.34%	+0.0%
DIIs	0.00%	0.21%	0.00%	0.00%	—
Public	33.66%	33.45%	33.66%	33.66%	+0.0%
No. of Shareholders	787	712	700	671	-4.1%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	VIJAYA Vijaya Diagnostic	₹1,507.80	15,530	82.7	857	187	42.3%	21.8%	19.5%	20.2%	22.8%	37.3%
2	METROPOLIS Metropolis Healthcare	₹596.30	12,370	61.1	1,710	203	24.7%	11.9%	23.6%	31.4%	16.6%	25.7%
3	HCG Healthcare Global	₹704.05	10,512	390.9	2,626	33	18.2%	1.3%	14.6%	-53.3%	13.1%	175.3%
4	YATHARTH Yatharth Hospital	₹988.90	9,528	54.1	1,200	171	23.6%	14.3%	36.2%	31.6%	47.6%	16.2%
5	JLHL Jupiter Life	₹277.85	9,109	9.7	1,557	187	22.1%	12.0%	20.9%	-6.7%	18.2%	-14.5%
6	THYROCARE Thyrocare Technologies	₹555.45	8,841	50.0	876	176	32.1%	20.1%	20.8%	79.4%	24.3%	33.2%
7	KOVAI Kovai Medical	₹6,260.50	6,850	26.7	1,644	256	27.9%	15.6%	15.7%	16.7%	15.3%	20.6%
8	INDRAMEDCO Indraprastha Medical	₹363.20	3,330	17.7	1,524	188	18.0%	12.4%	9.3%	13.7%	11.3%	9.5%
9	KRSNAA Krsnaa Diagnostics	₹543.40	1,763	18.1	816	98	26.8%	12.0%	7.8%	31.0%	22.1%	-19.3%
10	SURAKSHA Suraksha Diagnostic	₹311.85	1,624	45.3	325	35	31.4%	10.8%	23.1%	1.4%	20.7%	40.0%
11	SHALBY Shalby	₹132.15	1,418	38.0	1,176	37	12.1%	3.2%	5.0%	1683.0%	11.7%	36.7%
12	GPTHEALTH GPT Healthcare	₹157.90	1,296	27.4	491	48	18.5%	9.8%	15.1%	-21.9%	17.8%	62.5%
13	LAXMIDENTL Laxmi Dental	₹196.21	1,080	35.0	287	31	16.2%	10.9%	16.0%	-10.1%	13.2%	28.9%
14	NEPHROCARE Nephro Care	₹234.80	387	—	—	—	—	—	—	—	68.4%	347.7%
15	LOTUSEYE Lotus Eye	₹114.50	243	n/m	57	0	8.5%	0.3%	8.4%	-89.1%	26.2%	13.0%
16	UNIHEALTH Unihealth Hospitals	₹121.00	190	6.5	132	46	40.9%	34.8%	—	—	104.6%	71.5%
17	MADHAVBAUG Vaidya Sane	₹148.00	156	19.1	147	8	11.4%	5.6%	—	—	116.1%	94.3%
18	MHHL Mohini Health	₹57.05	104	—	145	-17	-1.4%	-11.7%	—	—	-6.6%	-1400.0%
19	MAITREYA Maitreya Medicare	₹120.65	82	—	45	-2	-1.0%	-5.5%	—	—	-5.2%	-1720.0%
20	AATMAJ Aatmaj Healthcare	₹26.75	60	83.6	24	1	9.7%	2.9%	—	—	22.5%	-39.4%
21	NIDAN Nidan Laborator.	₹33.00	46	30.6	26	2	19.0%	5.9%	—	—	-11.2%	-92.0%
22	ARTEMISMED Artemis Medicare	₹315.00	—	48.0	1,081	103	17.4%	9.6%	15.4%	25.9%	16.3%	30.9%

❓ Frequently asked questions

What was Vaidya Sane Ayurved Laboratories Limited's revenue in Q4 FY26?